Estimating the value of intravenous calcium and magnesium in ameliorating oxaliplatin-induced neuropathy
- PMID: 25135996
- DOI: 10.1200/JCO.2014.56.5424
Estimating the value of intravenous calcium and magnesium in ameliorating oxaliplatin-induced neuropathy
Comment in
-
Reply to C.d. Atkins and a. Avan et Al.J Clin Oncol. 2014 Oct 10;32(29):3342-3. doi: 10.1200/JCO.2014.57.2537. Epub 2014 Aug 18. J Clin Oncol. 2014. PMID: 25135995 No abstract available.
Comment on
-
Intravenous calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer: NCCTG N04C7.J Clin Oncol. 2011 Feb 1;29(4):421-7. doi: 10.1200/JCO.2010.31.5911. Epub 2010 Dec 28. J Clin Oncol. 2011. PMID: 21189381 Free PMC article. Clinical Trial.
-
Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance).J Clin Oncol. 2014 Apr 1;32(10):997-1005. doi: 10.1200/JCO.2013.52.0536. Epub 2013 Dec 2. J Clin Oncol. 2014. PMID: 24297951 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical